Cell & Gene Therapy
Dev-On-Demand
Our global cell & gene therapies (CGT) development team of 100+ scientists is spread across three locations in the United States and Europe, in State-of-the-Art CGT dedicated laboratories, fully equipped with the latest technologies in the space for the process and assay development of cell therapies, gene therapies and viral vectors.
With Dev-On-Demand, we empower biotech companies to continue developing their process in-house, by giving them the opportunity to tap into our scientific team’s knowledge, expertise and capabilities for specific challenges, trouble-shooting or individual development step and advance their process.
Request to be contacted
Here are the focus areas we can trouble-shoot and where we can help you to leapfrog your process:
- Medium development
- 2D / 3D cell culture system development
- Somatic and pluripotent stem cells, including iPSC lines generation
- Research-grade cell and viral banks development
- Process scale-up studies
- Assays development and optimization
- Characterization and non-GMP stability testing of products
- Cell isolation
- Gene modification
- Cryopreservation studies
- Cell washing / concentration
- Evaluation / Production of feeder cell-line
Watch our webinar to discover process development best practices
for CGT commercialization readiness
Interested in learning more about our offering?
View our complete Process Development Offering for more information
